(Q34182008)

31 July 2017

1 reference

title

Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression (English)

1 reference

31 July 2017

0 references

Mace S

1

1 reference

PubMed ID

11249500

31 July 2017

Taylor D

series ordinal

2

1 reference

PubMed ID

11249500

31 July 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

Expert Opinion on Pharmacotherapy

31 July 2017

1 reference

31 July 2017

1

1 reference

31 July 2017

917-933

1 reference

31 July 2017

5

1 reference

A comparison of fluvoxamine and fluoxetine in the treatment of major depression

31 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.917

A Double-Blind Study of Paroxetine, Fluoxetine, and Placebo in Outpatients with Major Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.917

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.917

Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.917

Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.917

Moclobemide versus fluoxetine for double depression: a randomized double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.917

Moclobemide versus fluoxetine for a major depressive episode

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.917

Selective serotonin-reuptake inhibitor-induced movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.917

Serotonin reuptake inhibitor withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.917

A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.917

Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.917

Safety of abrupt discontinuation of fluoxetine: a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.917

A comparison of paroxetine and placebo in depressed outpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.917

A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.917

21 January 2018

Identifiers

DOI

10.1517/14656566.1.5.917

1 reference

31 July 2017

1 reference

PubMed ID

11249500